Reshape Lifesciences Inc.
13F holders, Q4 2024 (December 31)1holders −1
0new positions
1sold out
$4.33avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Reshape Lifesciences Inc. in their 13F filings, down 1 from Q3 2024. 0 opened new positions and 1 sold out. The largest holder was Cornerstone Planning Group LLC ($13).
- Company
- Reshape Lifesciences Inc.
- CUSIP
- 76090R200
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $6 |
All 13F filers, Q3 2024 → Q4 2024: 1 shares sold, net −1 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Cornerstone Planning Group LLC | 0.00% | No change | 3 | $13 |
"% of holder's portfolio" is RESHAPE LIFESCIENCES INC's weight in each manager's 13F, not the share of Reshape Lifesciences Inc. the manager owns.